Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 156 | 100 | 132 | 49 | 38 |
| Income taxes - deferred | -96 | 392 | 420 | 7 | 411 |
| Accounts receivable | -2,128 | -4,344 | -1,471 | 45 | -1,101 |
| Accounts payable and accrued liabilities | 931 | 565 | -5 | -1,122 | 1,615 |
| Other Working Capital | -1,310 | -3,115 | 387 | -969 | 3,582 |
| Other Operating Activity | 5,180 | 10,790 | 3,619 | 2,557 | 5,788 |
| Operating Cash Flow | $2,733 | $4,388 | $3,082 | $567 | $10,333 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 2,157 | 0 | N/A | 0 | 1,745 |
| Purchase Of Investment | -98,883 | -171,903 | -143,117 | -156,865 | -138,522 |
| Sale Of Investment | 132,657 | 188,207 | 82,494 | 155,636 | 99,798 |
| Purchase Sale Intangibles | -6,562 | -367 | 0 | -2,924 | N/A |
| Other Investing Activity | -1,420 | 4,889 | -1,593 | -31,410 | 21,223 |
| Investing Cash Flow | $27,949 | $20,826 | $-62,216 | $-35,563 | $-15,756 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 95,069 | 24 | 218,574 | 28 | 12,446 |
| Common Stock Repurchased | -150 | -16 | -200 | N/A | 0 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -12,425 |
| Financing Cash Flow | $94,919 | $8 | $218,374 | $28 | $21 |
| Exchange Rate Effect | -61 | 467 | -312 | 2,272 | -3,723 |
| Beginning Cash Position | 389,402 | 363,713 | 204,785 | 237,481 | 246,606 |
| End Cash Position | 514,942 | 389,402 | 363,713 | 204,785 | 237,481 |
| Net Cash Flow | $125,601 | $25,222 | $159,240 | $-34,968 | $-5,402 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,733 | 4,388 | 3,082 | 567 | 10,333 |
| Capital Expenditure | -6,569 | -367 | N/A | -2,924 | N/A |
| Free Cash Flow | -3,836 | 4,021 | 3,082 | -2,357 | 10,333 |